AI assistant
Sending…
Cardiff Oncology, Inc. — Director's Dealing 2018
Jun 11, 2018
33967_dirs_2018-06-11_77528207-882c-49ab-a313-e04ef43957f2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Trovagene, Inc. (TROV)
CIK: 0001213037
Period of Report: 2018-06-08
Reporting Person: BRANCACCIO JOHN P (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-06-08 | Common Stock | P | 10000 | $0.80 | Acquired | 53167 | Direct |
More from Cardiff Oncology, Inc.
Regulatory Filings
2026
May 29
Regulatory Filings
2026
May 19
Regulatory Filings
2026
May 14
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
Apr 9
Regulatory Filings
2026
Feb 25
Regulatory Filings
2026
Feb 24
Annual Report
2026
Feb 24
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18